Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: EDAP TMS S.A.

Market Cap 17Cr 15Cr 14Cr 13Cr 24Cr 1.67TCr 25Cr 166.67Cr 65Cr 806.17Cr 66Cr 64Cr 2.8TCr P/E Ratio 2026 *
-5.28x
P/E Ratio 2027 * -6.79x
Enterprise Value 17Cr 15Cr 14Cr 13Cr 24Cr 1.67TCr 25Cr 166.67Cr 65Cr 806.17Cr 66Cr 64Cr 2.8TCr EV / Sales 2026 *
2.6x
EV / Sales 2027 * 2.38x
Free-Float
32.89%
Yield 2026 *
-
Yield 2027 * -
1 week+2.56%
Current month+9.89%
1 month+19.05%
3 months+11.11%
6 months+112.77%
Current year+50.38%
1 week 3.76
Extreme 3.76
4.06
1 month 3.32
Extreme 3.32
4.06
3 years 1.03
Extreme 1.03
8.3
5 years 1.03
Extreme 1.03
11.5
10 years 1.03
Extreme 1.03
11.5
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2023
Director of Finance/CFO 55 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 64 01/05/2023
Chairman 64 01/09/2024
Director/Board Member 62 08/07/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+2.56%+172.11%-50.92% 17Cr
-1.51%-1.71%+14.12%-9.53% 18TCr
+0.70%-1.22%-20.81%+31.90% 15TCr
-1.30%-3.30%-11.84%-24.18% 13TCr
-1.15%-2.74%-52.20%-7.21% 7.19TCr
+0.81%-1.12%+14.58%+1.05% 4.95TCr
-1.99%-0.72%-26.09%-34.75% 4.52TCr
-1.76%-6.53%+8.03%+9.10% 3.72TCr
-0.76%-4.54%+3.85%+39.88% 3.57TCr
+1.66%+1.07%-12.14%-17.61% 2.9TCr
Average -0.45%+1.21%+8.96%-6.23% 8.04TCr
Weighted average by Cap. -0.62%+1.56%-8.49%-1.37%

Financials

2026 *2027 *
Net sales 6.72Cr 5.83Cr 5.37Cr 5.04Cr 9.41Cr 643.24Cr 9.6Cr 64Cr 25Cr 310.06Cr 25Cr 25Cr 1.08TCr 7.33Cr 6.36Cr 5.86Cr 5.49Cr 10Cr 701.91Cr 10Cr 70Cr 27Cr 338.34Cr 28Cr 27Cr 1.18TCr
Net income -3.32Cr -2.88Cr -2.65Cr -2.49Cr -4.65Cr -317.66Cr -4.74Cr -32Cr -12Cr -153.12Cr -12Cr -12Cr -532.41Cr -2.79Cr -2.42Cr -2.23Cr -2.09Cr -3.91Cr -267.46Cr -3.99Cr -27Cr -10Cr -128.93Cr -10Cr -10Cr -448.28Cr
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
-
Date Price Change
11/26/11 4.020 +0.50%
10/26/10 4.000 +2.04%
09/26/09 3.920 +0.51%
08/26/08 3.900 0.00%
05/26/05 3.900 -0.51%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.660USD
Average target price
5.833USD
Spread / Average Target
+25.18%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!